Remodulin (United Therapeutics Corporation)
Welcome to the PulseAid listing for the Remodulin drug offered from United Therapeutics Corporation. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | United Therapeutics Corporation |
| NON-PROPRIETARY NAME: | treprostinil |
| SUBSTANCE NAME: | TREPROSTINIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-05-22 |
| END MARKETING DATE: | 0000-00-00 |
Remodulin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Remodulin from United Therapeutics Corporation |
| LABELER NAME: | United Therapeutics Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/20mL) |
| START MARKETING DATE: | 2002-05-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66302-101_0e32b5b0-743d-49e5-b314-6b436e5211e3 |
| PRODUCT NDC: | 66302-101 |
| APPLICATION NUMBER: | NDA021272 |
Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers:
